Literature DB >> 16955257

Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS.

Qiang Zhang1, Peng Ma, Richard B Cole, Guangdi Wang.   

Abstract

The in vitro microsomal metabolism of JWH-015, a ligand that exhibits a high binding affinity at the peripheral cannabinoid receptor CB(2), has been studied. A total of 22 metabolites were identified and structurally characterized. The metabolites are products of: 1) monohydroxylation on the naphthalene ring (m/z 344, M20 and M21), indole ring (m/z 344, M17 and M18), or the N-alkyl group (m/z 344, M14); 2) arene oxidation leading to dihydrodiols (m/z 362, M12 and M15); 3) dihydroxylation on the naphthalene ring (m/z 360, M7) or indole ring (m/z 360, M13), resulting from a combination of monohydroxylations on both the naphthalene and indole rings (m/z 360, M16), or a combination of monohydroxylations on the naphthalene ring and on the N-propyl group (m/z 360, M9); 4) trihydroxylation (m/z 378, M1, M3, M4, M6, and M10); 5) N-dealkylation (m/z 286, M19); 6) N-dealkylation and monohydroxylation on the naphthalene ring (m/z 302, M11); 7) N-dealkylation and dihydrodiol formation from arene oxidation (m/z 320, M2 and M5); 8) dehydrogenation after monohydroxylation on the N-alkyl group (m/z 326, M22); 9) dehydrogenation and monohydroxylation on the indole ring (m/z 342, M8).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16955257     DOI: 10.1007/s00216-006-0717-6

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  14 in total

1.  Detection and disposition of JWH-018 and JWH-073 in mice after exposure to "Magic Gold" smoke.

Authors:  Justin L Poklis; Dorra Amira; Laura E Wise; Jason M Wiebelhaus; Brenda J Haggerty; Alphonse Poklis
Journal:  Forensic Sci Int       Date:  2012-03-08       Impact factor: 2.395

2.  Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to 'buzz' smoke by HPLC/MS/MS.

Authors:  Justin L Poklis; Dorra Amira; Laura E Wise; Jason M Wiebelhaus; Brenda J Haggerty; Aron H Lichtman; Alphonse Poklis
Journal:  Biomed Chromatogr       Date:  2012-03-08       Impact factor: 1.902

3.  Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA.

Authors:  Ariane Wohlfarth; Marisol S Castaneto; Mingshe Zhu; Shaokun Pang; Karl B Scheidweiler; Robert Kronstrand; Marilyn A Huestis
Journal:  AAPS J       Date:  2015-02-28       Impact factor: 4.009

Review 4.  Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Authors:  William E Fantegrossi; Jeffery H Moran; Anna Radominska-Pandya; Paul L Prather
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

Review 5.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

6.  Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine.

Authors:  Krishna C Chimalakonda; Cindy L Moran; Paul D Kennedy; Gregory W Endres; Adam Uzieblo; Paul J Dobrowolski; E Kim Fifer; Jeff Lapoint; Lewis S Nelson; Robert S Hoffman; Laura P James; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Anal Chem       Date:  2011-07-27       Impact factor: 6.986

Review 7.  Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites.

Authors:  Sherrica Tai; William E Fantegrossi
Journal:  Curr Top Behav Neurosci       Date:  2017

8.  Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases.

Authors:  Krishna C Chimalakonda; Stacie M Bratton; Vi-Huyen Le; Kan Hui Yiew; Anna Dineva; Cindy L Moran; Laura P James; Jeffery H Moran; Anna Radominska-Pandya
Journal:  Drug Metab Dispos       Date:  2011-07-11       Impact factor: 3.922

9.  In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes.

Authors:  Qiang Zhang; Peng Ma; Richard B Cole; Guangdi Wang
Journal:  Eur J Pharm Sci       Date:  2010-06-11       Impact factor: 4.384

10.  Therapeutic modulation of cannabinoid lipid signaling: metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist.

Authors:  Jodianne T Wood; Dustin M Smith; David R Janero; Alexander M Zvonok; Alexandros Makriyannis
Journal:  Life Sci       Date:  2012-06-28       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.